Laurus Labs share news, announcements and annual reports
NSE: LAURUSLABSBSE: 540222Pharmaceuticals & BiotechnologyMid Cap
Share price at the NSE close on 29 Oct 2026. Previous close ₹2,181.90.
29 Oct: open ₹2,190.00, high ₹2,244.00, low ₹2,166.00
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹1,21,246 Cr171st largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 90.49
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 20.01
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.09%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 24.7%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 21.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.40
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 29,00,78934.1% delivered
Laurus Labs results
41 filed, newest first.
Oct 2026
29 Oct · Results
Jul 2026
24 Jul · Results
Apr 2026
30 Apr · Results
Jan 2026
23 Jan · Results
Oct 2025
23 Oct · Results
Jul 2025
25 Jul · Results
Apr 2025
24 Apr · Results
Jan 2025
24 Jan · Results
24 Jan · Results
Oct 2024
24 Oct · Results
Jul 2024
25 Jul · Results
Apr 2024
25 Apr · Results
Jan 2024
24 Jan · Results
Oct 2023
20 Oct · Results
Jul 2023
27 Jul · Results
Apr 2023
27 Apr · Results
Jan 2023
30 Jan · Results
Jul 2022
Apr 2022
28 Apr · Results
Jan 2022
27 Jan · Results
Oct 2021
28 Oct · Results
Jul 2021
29 Jul · Results
Apr 2021
29 Apr · Results
Jan 2021
28 Jan · Results
Oct 2020
29 Oct · Results
Jul 2020
30 Jul · Results
Apr 2020
30 Apr · Results
Jan 2020
30 Jan · Results
Oct 2019
31 Oct · Results
Aug 2019
2 Aug · Results
May 2019
2 May · Results
Jan 2019
31 Jan · Results
Nov 2018
1 Nov · Results
Aug 2018
3 Aug · Results
May 2018
10 May · Results
Jan 2018
29 Jan · Results
Nov 2017
9 Nov · Results
Sep 2017
11 Sep · Results
Aug 2017
May 2017
18 May · Results
Feb 2017
9 Feb · Results